Yuli Wei
Tianjin Key Laboratory Of Molecular Drug Research
Tianjin, 300457, China
Tianjin, 300457, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Baricitinib Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice by Inhibiting TGF-β1 Signaling Pathway.
Journal: Molecules (Basel, Switzerland)
Published: December 30, 2022
Zanubrutinib attenuates bleomycin-induced pulmonary fibrosis by inhibiting the TGF-β1 signaling pathway.
Journal: International immunopharmacology
Published: July 09, 2022
Zanubrutinib ameliorates lipopolysaccharide-induced acute lung injury via regulating macrophage polarization.
Journal: International immunopharmacology
Published: April 18, 2022
Isorhamnetin alleviates lipopolysaccharide-induced acute lung injury by inhibiting mTOR signaling pathway.
Journal: Immunopharmacology and immunotoxicology
Published: March 21, 2022
Cabozantinib ameliorates lipopolysaccharide-induced lung inflammation and bleomycin--induced early pulmonary fibrosis in mice.
Journal: International immunopharmacology
Published: August 18, 2021
Effect of dihydromyricetin on SARS-CoV-2 viral replication and pulmonary inflammation and fibrosis.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: April 21, 2021
Bergenin attenuates bleomycin-induced pulmonary fibrosis in mice via inhibiting TGF-β1 signaling pathway.
Journal: Phytotherapy research : PTR
Published: April 10, 2021
Regorafenib-Attenuated, Bleomycin-Induced Pulmonary Fibrosis by Inhibiting the TGF-β1 Signaling Pathway.
Journal: International journal of molecular sciences
Published: January 15, 2021
Ellagic Acid Attenuates BLM-Induced Pulmonary Fibrosis via Inhibiting Wnt Signaling Pathway.
Journal: Frontiers in pharmacology
Published: December 09, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026